AbbVie Inc. (ABBV) Operating cash flow 2016–2025
AbbVie Inc. (ABBV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$19.0BFY2025 · since FY2016: $7.0B → $19.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $19.0B | +1.2% |
| FY2024 | $18.8B | -17.7% |
| FY2023 | $22.8B | -8.4% |
| FY2022 | $24.9B | +9.5% |
| FY2021 | $22.8B | +29.5% |
| FY2020 | $17.6B | +32.0% |
| FY2019 | $13.3B | -0.8% |
| FY2018 | $13.4B | +34.8% |
| FY2017 | $10.0B | +41.5% |
| FY2016 | $7.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice